Heat shock proteins in cancer: targeting the 'chaperones'

Future Medicinal Chemistry
Z NahlehZ Nahle

Abstract

Heat shock proteins (Hsps) are highly conserved proteins working as molecular chaperones for several cellular proteins essential for normal cell viability and growth, and have numerous cytoprotective roles. The expression of Hsps is induced in response to a wide variety of physiological and environmental stress insults, including anticancer chemotherapy, thus allowing the cell to survive lethal conditions. Cancer cells experience high levels of proteotoxic stress and rely upon stress-response pathways for survival and proliferation, thereby becoming dependent on proteins such as stress-inducible Hsps. Owing to the implication of Hsps in cancer, Hsp inhibition has recently emerged as an interesting potential anticancer strategy. Many natural and synthetic Hsp inhibitors molecular compounds are in development and many are being evaluated as potential cancer therapies. One of the Hsps in particular, Hsp90, has several client proteins and is emerging as a particularly exciting cancer target due to the prospect of simultaneously inhibiting chaperoning of numerous oncogenic proteins. This review describes the function of Hsps focusing on current efforts in exploiting the attributes of Hsps as potential targets for anticancer therapy.

References

Jan 1, 1995·Cancer Chemotherapy and Pharmacology·J G SupkoL Malspeis
Mar 3, 1995·International Journal of Cancer. Journal International Du Cancer·M Jäättelä
Oct 6, 1993·Journal of the National Cancer Institute·D R CioccaS A Fuqua
Sep 25, 1999·The New England Journal of Medicine·P L Hooper
Nov 26, 1999·Breast Cancer Research and Treatment·R K HansenS A Fuqua
Sep 12, 2000·Nature Cell Biology·J M BrueyC Garrido
Sep 5, 2001·Nature Cell Biology·L RavagnanG Kroemer
Feb 4, 2003·Experimental Biology and Medicine·William B Pratt, David O Toft
Aug 5, 2003·Molecular and Cellular Biology·Arnaud ParcellierCarmen Garrido
Oct 16, 2003·Trends in Biochemical Sciences·Jason C YoungF Ulrich Hartl
Oct 29, 2003·Experimental Gerontology·Csaba Soti, Péter Csermely
Dec 10, 2003·Oncogene·Shinichi TakayamaSachiko Homma
Dec 23, 2003·Cancer Immunology, Immunotherapy : CII·Chiara CastelliGiorgio Parmiani
Jan 24, 2004·Reviews of Physiology, Biochemistry and Pharmacology·H WegeleJ Buchner
Apr 9, 2004·FEBS Letters·Amere Subbarao SreedharYu-Fei Shen
May 8, 2004·Trends in Plant Science·Wangxia WangArie Altman
Oct 2, 2004·Nature Reviews. Molecular Cell Biology·Jason C YoungF Ulrich Hartl
Jul 26, 2005·Cell Stress & Chaperones·Daniel R Ciocca, Stuart K Calderwood
Sep 20, 2005·British Journal of Pharmacology·Csaba SõtiPéter Ferdinandy
Sep 22, 2005·Nature Reviews. Cancer·Luke Whitesell, Susan L Lindquist
Feb 18, 2006·Trends in Biochemical Sciences·Stuart K CalderwoodDaniel R Ciocca
May 2, 2006·Archivum Immunologiae Et Therapiae Experimentalis·Krzysztof Laudanski, Dorota Wyczechowska
Jun 8, 2006·Annual Review of Biochemistry·Laurence H Pearl, Chrisostomos Prodromou
Apr 6, 2007·Cancer Research·Elah PickHarriet M Kluger
Jan 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Toni K ChoueiriBernard Escudier
Jan 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sarat ChandarlapatyDavid B Solit

❮ Previous
Next ❯

Citations

May 11, 2013·Annals of the Rheumatic Diseases·Michal TomcikJörg H Distler
Feb 4, 2014·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Sayan Dutta GuptaN M Raghavendra
May 29, 2013·Drug Discovery Today·Lik Tong Tan
Apr 23, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Nate LarsonHamidreza Ghandehari
Jun 1, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ashutosh BarveKun Cheng
Jun 15, 2016·Cancer Chemotherapy and Pharmacology·Ting ZouZhaoqian Liu
Dec 5, 2012·Journal of Proteome Research·Helle MalerodSonja Hess
Feb 26, 2014·Journal of Chemical Information and Modeling·Flavio BallanteRino Ragno
May 5, 2017·International Journal of Molecular Sciences·Tiago Góss SantosGlaucia Noeli Maroso Hajj
Dec 21, 2016·British Journal of Sports Medicine·Robert James ThomasAlfonso Jimenez
Oct 19, 2019·International Journal of Molecular Sciences·Leonardo M R FerreiraAna M Urbano
Nov 2, 2013·Chemical Communications : Chem Comm·Takenori TomohiroYasumaru Hatanaka
May 19, 2019·Scientific Reports·Marta KlimczakMaciej Zylicz
Mar 10, 2020·BioMed Research International·Aurellia WhitmoreHernan Flores-Rozas
Feb 25, 2020·Database : the Journal of Biological Databases and Curation·Prashant SinghDeepak Sharma
Feb 3, 2021·Cells·Graham Chakafana, Addmore Shonhai
Dec 17, 2020·Clinical Breast Cancer·Hagar H FahimAbdallah M Gameel

❮ Previous
Next ❯

Methods Mentioned

BETA
immunodepletion
protein folding

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Len Neckers, Paul Workman
© 2021 Meta ULC. All rights reserved